The Technology Transfer, sitting at the AO Innovation Translation Center (AO ITC), advances innovation to improve patient care and surgeon education in musculoskeletal disorders, by translating in-house and external technologies from bench to bedside.
Responsible for the funding streams of the Development Incubator and Strategy Fund, the Technology Transfer is your one-stop shop providing multiyear investments as well as support to secure intellectual property, develop regulatory strategies, gain access to manufacturers, and connect you with the largest network of trauma and orthopedic health care professionals in the world.
The AO funds innovation in a number of ways
Strategy Fund seed funding aimed for innovative products, services, and technologies improving surgeon education or any element of the entire patient journey in musculoskeletal disorders
Early stage idea?
Development Incubator to support inventors from proof of concept to clinical implementation, mentored by an independent board with expertise in R&D, financing, clinical validation, manufacturing, and industrialization
Developing solutions toward clinical implementation?
Development IncubatorJuly 20, 2020
New AO project is poised to revolutionize tissue engineering
Strategy FundMay 29, 2020
A bold vision: New AO project to revolutionize spine and pelvis fracture treatment
AO Innovation Translation Center project uses strategy fund resources to transform patient care
Development IncubatorJuly 02, 2019
Inside the healing processAO Fracture Monitor helps clinicians understand and measure fracture healing
You might also be interested in
"As part of the AO Innovation Translation Center, the Technology Transfer office offers an opportunity for inventors to take vital steps toward applying their ideas to advance patient care."
Michael Schütz, Chair, Technology Transfer Board, AO ITC